Xingbo Cheng

521 citations
21 papers · 295 indexed · h-index 7
Topics
Ferroptosis and cancer prognosis (9 papers)Genetic Syndromes and Imprinting (4 papers)Epigenetics and DNA Methylation (4 papers)
Partner nations
ChinaUnited KingdomIndia

In The Last Decade

Xingbo Cheng

20 papers receiving 263 citations

Peers

Xingbo Cheng
Comparison fields: 5 of 59
  • Molecular Biology 167
  • Genetics 148
  • Pediatrics, Perinatology and Child Health 58
  • Cancer Research 50
  • Nephrology 22
Replace Florian Erger with:
Florian Erger Germany
Sandra Corbani Lebanon
Laurence Michel‐Calemard France
Kazuo Okimoto Japan
Martina Owens United Kingdom
Philip L. Beales United Kingdom
Cherie Stayner New Zealand
Patrick R. van den Berg Netherlands
Adam C. Gunning United Kingdom
Kim Jenny United States
Xingbo Cheng relative to Florian Erger Germany Florian Erger's profile →
Citations per field
00.5×1.5×
Florian Erger · 1×
Citations per year

Countries citing papers authored by Xingbo Cheng

Since Specialization
Citations

This map shows the geographic impact of Xingbo Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingbo Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingbo Cheng more than expected).

Fields of papers citing papers by Xingbo Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingbo Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingbo Cheng. The network helps show where Xingbo Cheng may publish in the future.

Co-authorship network of co-authors of Xingbo Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Xingbo Cheng. A scholar is included among the top collaborators of Xingbo Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingbo Cheng. Xingbo Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 2
5 4
6 1
7 2
8 3
9 12
10 1
11 15
12 5
13 5
14 6
15 63
16 1
17 21
18 5
19 66
20 25

About Xingbo Cheng

Xingbo Cheng is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 21 papers that have together received 295 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (9 papers), Genetic Syndromes and Imprinting (4 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Genetics (148 citations), Cancer Research (50 citations) and Nephrology (22 citations). Xingbo Cheng has collaborated with scholars based in China, United Kingdom and India. Frequent co-authors include Marcus Pembrey, S Malcolm, Jill Clayton‐Smith, T. Webb, Luping Chen, Xiaofeng Tang, Christopher T. Chan, Bei Zhu, Ming Cheng and M. Lalande. Their work appears in journals such as Gene, Current Medicinal Chemistry and Journal of Medical Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026